NCT00047515CompletedPhase 3
Phase III Safety and Efficacy Study to Evaluate Combination IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertensive Patients C-01-69.
Conditions
Drugs
Trial Snapshot
- Phase
- Phase 3
- Status
- Completed
- Sponsor
- Alcon Research
- Locations
- 1
Study Overview
Brief Summary
To compare intraocular pressure lowering effectiveness of a combination drug vs. two individual drugs dosed alone.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- Double
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Adult subjects of either sex and any race with open-angle glaucoma or ocular hypertension; visual acuity of 20/80 to 20/400 or better (Snellen equivalent) or logMAR visual acuity not worse than 0.
- •Clinically relevant ophthalmic or systemic conditions may be excluded.
Exclusion Criteria
- Not provided
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Completed
Phase 3
Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-02-41Ocular HypertensionOpen-Angle GlaucomaNCT00047528Alcon Research
Completed
Phase 3
Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-70Ocular HypertensionOpen-Angle GlaucomaNCT00047541Alcon Research
Completed
Phase 2
Clinical Study of A Fixed Combination of Timolol-Brimonidine-DorzolamidePrimary Open Angle GlaucomaOcular HypertensionNCT01062971Laboratorios Sophia S.A de C.V.124
Unknown
Phase 3
A Study of Efficacy and Safety of PHP-201 in Patients With Primary Open Angle Glaucoma or Ocular HypertensionOcular HypertensionPrimary Open Angle GlaucomaNCT04863365pH Pharma110
Completed
Phase 2
Evaluation of PHP-201 Ophthalmic Solution in Patients With Normal Tension GlaucomaNormal Tension GlaucomaNCT03106532pH Pharma119